Advocacy
Practice development
Johnson & Johnson MedTech announced that they’ve received a binding offer from Quantum Surgical Incorporated to acquire their NEUWAVE business line. J&J had previously announced that it was discontinuing this product, but the deal means that NEUWAVE will still be available for practices in the United States.
More news from SIR
-
Guidewire
![]()
Senate attempts to pause OMB grant-making rule
![]()
The Senate-passed CR would fund the government through Dec. 11 and temporarily block OMB’s proposed federal financial assistance rule. SIR joined other healthcare organizations in opposing the proposal.
-
Guidewire
![]()
CMS collecting comments on RAPID pathway for device coverage
![]()
CMS is seeking feedback on its proposed RAPID pathway, which could reduce the time from FDA authorization to Medicare coverage for eligible breakthrough devices.
Advocacy
Coding, billing and reimbursement
-
Guidewire
![]()
EMBOLIZE Trial takes center stage in SIR’s pain awareness month outreach
![]()
During Pain Awareness Month, SIR is highlighting chronic pelvic pain and promoting awareness of the EMBOLIZE Trial, which is evaluating embolization as a treatment option. Help support patient outreach and enrollment by sharing campaign resources.
IR research
Advocacy
-
Guidewire
![]()
SIR joins PAD Awareness Month campaign in September
![]()
SIR is supporting PAD Awareness Month through the PAD Pulse Alliance’s “Get a Pulse on PAD” campaign, sharing weekly patient education resources throughout September. Learn more and access resources.
Continuous education
Advocacy
-
Guidewire
![]()
Carrier advocacy coverage letter updates underway!
![]()
The Carrier Advocacy Workgroup is updating several coverage letters and developing a new resource on adrenal venous sampling (AVS) to reflect the latest evidence and payer policies.
Economics
-
Guidewire
![]()
Strengthen shared decision making with SIR’s Patient Information Brochures
![]()
SIR’s patient information brochures provide clear, evidence-based resources that support shared decision making and help patients better understand minimally invasive treatment options. Explore the collection in the IR Business Center.
Practice development
![]()
More news from SIR
![]()
-
Guidewire
Senate attempts to pause OMB grant-making rule
The Senate-passed CR would fund the government through Dec. 11 and temporarily block OMB’s proposed federal financial assistance rule. SIR joined other healthcare organizations in opposing the proposal.
-
Guidewire
CMS collecting comments on RAPID pathway for device coverage
CMS is seeking feedback on its proposed RAPID pathway, which could reduce the time from FDA authorization to Medicare coverage for eligible breakthrough devices.
Advocacy Coding, billing and reimbursement -
Guidewire
EMBOLIZE Trial takes center stage in SIR’s pain awareness month outreach
During Pain Awareness Month, SIR is highlighting chronic pelvic pain and promoting awareness of the EMBOLIZE Trial, which is evaluating embolization as a treatment option. Help support patient outreach and enrollment by sharing campaign resources.
IR research Advocacy -
Guidewire
SIR joins PAD Awareness Month campaign in September
SIR is supporting PAD Awareness Month through the PAD Pulse Alliance’s “Get a Pulse on PAD” campaign, sharing weekly patient education resources throughout September. Learn more and access resources.
Continuous education Advocacy -
Guidewire
Carrier advocacy coverage letter updates underway!
The Carrier Advocacy Workgroup is updating several coverage letters and developing a new resource on adrenal venous sampling (AVS) to reflect the latest evidence and payer policies.
Economics -
Guidewire
Strengthen shared decision making with SIR’s Patient Information Brochures
SIR’s patient information brochures provide clear, evidence-based resources that support shared decision making and help patients better understand minimally invasive treatment options. Explore the collection in the IR Business Center.
Practice development
More news from SIR